A method for promoting the accumulation of secondary metabolites of cannabis is disclosed. The method comprises the step of adding an irradiation of green-yellow light, which has a peak wavelength at 505-590 nm, into the indoor growing environment of cannabis to improve the level of cannabidiol (CBD), secondary metabolites in cannabis. While maintaining the light intensity and other growth conditions, the yield and/or level of CBD, secondary metabolites in cannabis, can be increased by up to 11.04%.

A method for promoting the accumulation of secondary metabolites of cannabis is disclosed. The method comprises the step of adding an irradiation of green-yellow light, which has a peak wavelength at 505-590 nm, into the indoor growing environment of cannabis to improve the level of cannabidiol (CBD), secondary metabolites in cannabis. While maintaining the light intensity and other growth conditions, the yield and/or level of CBD, secondary metabolites in cannabis, can be increased by up to 11.04%.

The unique annual herbaceous Cannabis plant variety ‘BAGZXCD6-PA #2’ is provided. ‘BAGZXCD6-PA #2’ is a terpinolene-dominant variety with a shorter 9-week flowering period.

The unique annual herbaceous Cannabis plant variety ‘BAGZXCD6-PA #2’ is provided. ‘BAGZXCD6-PA #2’ is a terpinolene-dominant variety with a shorter 9-week flowering period.

An oil extraction apparatus includes an ultrasonication vessel that receives raw plant material and ethanol. An ultrasonication probe ultrasonicates the raw plant material received in the ultrasonication vessel and generates a mixture including ultrasonicated raw plant material, plant oil, and ethanol. A collection vessel is in fluid communication with the ultrasonication vessel. The collection vessel receives a mixture including plant oil and ethanol from the ultrasonication vessel. A heater heats the collection vessel to separate ethanol from the mixture including plant oil and ethanol. A reclamation vessel is in fluid communication with the collection vessel. The reclamation vessel receives separated ethanol from the mixture including plant oil and ethanol. An ethanol collection tube is connected with the reclamation vessel. The ethanol collection tube is arranged to carry separated ethanol from the mixture including plant oil and ethanol to the reclamation vessel from the collection vessel.

An oil extraction apparatus includes an ultrasonication vessel that receives raw plant material and ethanol. An ultrasonication probe ultrasonicates the raw plant material received in the ultrasonication vessel and generates a mixture including ultrasonicated raw plant material, plant oil, and ethanol. A collection vessel is in fluid communication with the ultrasonication vessel. The collection vessel receives a mixture including plant oil and ethanol from the ultrasonication vessel. A heater heats the collection vessel to separate ethanol from the mixture including plant oil and ethanol. A reclamation vessel is in fluid communication with the collection vessel. The reclamation vessel receives separated ethanol from the mixture including plant oil and ethanol. An ethanol collection tube is connected with the reclamation vessel. The ethanol collection tube is arranged to carry separated ethanol from the mixture including plant oil and ethanol to the reclamation vessel from the collection vessel.

A method of producing cannabinoids for use in medical treatments by growing cultured Cannabis sativa plant cells through tissue culture, the method comprising the steps of: selecting Cannabis sativa leaf tissue for culture; and growing a tissue culture from the selected leaf tissue in a liquid based medium whilst controlling the light exposure of the tissue culture to control the cannabinoid content of the tissue culture. Control of the light exposure can enable the phytocannabinoid content of the grown tissue culture to be tailored to the use intended for the tissue culture. For example, the THC content of the tissue culture can be controlled to be maximised or minimised depending on the intended use. Use of tissue culture is beneficial as compared to prior art methods as it allows for genetic consistency and reduces the resources necessary to produce plant cells containing phytocannabinoids.

A method of producing cannabinoids for use in medical treatments by growing cultured Cannabis sativa plant cells through tissue culture, the method comprising the steps of: selecting Cannabis sativa leaf tissue for culture; and growing a tissue culture from the selected leaf tissue in a liquid based medium whilst controlling the light exposure of the tissue culture to control the cannabinoid content of the tissue culture. Control of the light exposure can enable the phytocannabinoid content of the grown tissue culture to be tailored to the use intended for the tissue culture. For example, the THC content of the tissue culture can be controlled to be maximised or minimised depending on the intended use. Use of tissue culture is beneficial as compared to prior art methods as it allows for genetic consistency and reduces the resources necessary to produce plant cells containing phytocannabinoids.

A new hop plant named ‘HBC 735’ is disclosed. ‘HBC 735’ is used for its exceptional and unique aromatic qualities, and is suitable for beer flavoring.

The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.